Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Fluoride Alters Klk4 Expression in Maturation Ameloblasts through Androgen and Progesterone Receptor Signaling.

Le MH, Nakano Y, Abduweli Uyghurturk D, Zhu L, Den Besten PK.

Front Physiol. 2017 Nov 14;8:925. doi: 10.3389/fphys.2017.00925. eCollection 2017.

2.

Cell cycle-coupled expansion of AR activity promotes cancer progression.

McNair C, Urbanucci A, Comstock CE, Augello MA, Goodwin JF, Launchbury R, Zhao SG, Schiewer MJ, Ertel A, Karnes J, Davicioni E, Wang L, Wang Q, Mills IG, Feng FY, Li W, Carroll JS, Knudsen KE.

Oncogene. 2017 Mar 23;36(12):1655-1668. doi: 10.1038/onc.2016.334. Epub 2016 Sep 26.

3.

Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation.

Kamarajugadda S, Becker JR, Hanse EA, Mashek DG, Mashek MT, Hendrickson AM, Mullany LK, Albrecht JH.

Oncotarget. 2016 Jul 26;7(30):47674-47686. doi: 10.18632/oncotarget.10274.

4.

Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors.

Bendris N, Lemmers B, Blanchard JM.

Cell Cycle. 2015;14(12):1786-98. doi: 10.1080/15384101.2014.998085. Review.

5.

Consequence of the tumor-associated conversion to cyclin D1b.

Augello MA, Berman-Booty LD, Carr R 3rd, Yoshida A, Dean JL, Schiewer MJ, Feng FY, Tomlins SA, Gao E, Koch WJ, Benovic JL, Diehl JA, Knudsen KE.

EMBO Mol Med. 2015 May;7(5):628-47. doi: 10.15252/emmm.201404242.

6.

Characterization of the genomic architecture and mutational spectrum of a small cell prostate carcinoma.

Scott AF, Mohr DW, Ling H, Scharpf RB, Zhang P, Liptak GS.

Genes (Basel). 2014 May 12;5(2):366-84. doi: 10.3390/genes5020366.

7.

Cyclin D2 is a GATA4 cofactor in cardiogenesis.

Yamak A, Latinkic BV, Dali R, Temsah R, Nemer M.

Proc Natl Acad Sci U S A. 2014 Jan 28;111(4):1415-20. doi: 10.1073/pnas.1312993111. Epub 2014 Jan 13.

8.

AR function in promoting metastatic prostate cancer.

Augello MA, Den RB, Knudsen KE.

Cancer Metastasis Rev. 2014 Sep;33(2-3):399-411. doi: 10.1007/s10555-013-9471-3. Review.

9.

Targeting cell cycle and hormone receptor pathways in cancer.

Comstock CE, Augello MA, Goodwin JF, de Leeuw R, Schiewer MJ, Ostrander WF Jr, Burkhart RA, McClendon AK, McCue PA, Trabulsi EJ, Lallas CD, Gomella LG, Centenera MM, Brody JR, Butler LM, Tilley WD, Knudsen KE.

Oncogene. 2013 Nov 28;32(48):5481-91. doi: 10.1038/onc.2013.83. Epub 2013 May 27.

10.

Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models.

Tesei A, Leonetti C, Di Donato M, Gabucci E, Porru M, Varchi G, Guerrini A, Amadori D, Arienti C, Pignatta S, Paganelli G, Caraglia M, Castoria G, Zoli W.

PLoS One. 2013 May 8;8(5):e62657. doi: 10.1371/journal.pone.0062657. Print 2013.

11.

Transcriptional activity of c-Jun is critical for the suppression of AR function.

Hsu CC, Hu CD.

Mol Cell Endocrinol. 2013 Jun 15;372(1-2):12-22. doi: 10.1016/j.mce.2013.03.004. Epub 2013 Mar 21.

12.

Betulinic acid selectively increases protein degradation and enhances prostate cancer-specific apoptosis: possible role for inhibition of deubiquitinase activity.

Reiner T, Parrondo R, de Las Pozas A, Palenzuela D, Perez-Stable C.

PLoS One. 2013;8(2):e56234. doi: 10.1371/journal.pone.0056234. Epub 2013 Feb 12.

13.

Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.

Augello MA, Burd CJ, Birbe R, McNair C, Ertel A, Magee MS, Frigo DE, Wilder-Romans K, Shilkrut M, Han S, Jernigan DL, Dean JL, Fatatis A, McDonnell DP, Visakorpi T, Feng FY, Knudsen KE.

J Clin Invest. 2013 Jan;123(1):493-508. doi: 10.1172/JCI64750. Epub 2012 Dec 21.

14.

Modeling a lethal prostate cancer variant with small-cell carcinoma features.

Tzelepi V, Zhang J, Lu JF, Kleb B, Wu G, Wan X, Hoang A, Efstathiou E, Sircar K, Navone NM, Troncoso P, Liang S, Logothetis CJ, Maity SN, Aparicio AM.

Clin Cancer Res. 2012 Feb 1;18(3):666-77. doi: 10.1158/1078-0432.CCR-11-1867. Epub 2011 Dec 12.

15.

The AR dependent cell cycle: mechanisms and cancer relevance.

Schiewer MJ, Augello MA, Knudsen KE.

Mol Cell Endocrinol. 2012 Apr 16;352(1-2):34-45. doi: 10.1016/j.mce.2011.06.033. Epub 2011 Jul 12. Review.

Supplemental Content

Support Center